Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Lymphoma 225 Lymphoma, Large B-Cell, Diffuse 160 Small Cell Lung Carcinoma 155 Precursor Cell Lymphoblastic Leukemia-Lymphoma 143 Lymphoma, Non-Hodgkin 139 Leukemia 135 Leukemia, Myeloid, Acute 117 Hodgkin Disease 106 Burkitt Lymphoma 99 Lung Neoplasms 98 Lymphoma, Follicular 85 Lymphoma, Mantle-Cell 76 Lymphoma, Large-Cell, Immunoblastic 68 Carcinoma, Non-Small-Cell Lung 61 Neuroblastoma 60 Leukemia, Lymphocytic, Chronic, B-Cell 56 Recurrence 53 Multiple Myeloma 52 Lymphoma, B-Cell, Marginal Zone 43 Congenital Abnormalities 43 Sarcoma 39 Central Nervous System Neoplasms 39 Myelodysplastic Syndromes 35 Brain Neoplasms 34 Ovarian Neoplasms 32 Leukemia, Myelomonocytic, Acute 32 Lymphoma, B-Cell 31 Leukemia, Monocytic, Acute 31 Leukemia, Erythroblastic, Acute 31 Testicular Neoplasms 30

Interventions

midostaurin 2 vandetanib 1 selinexor 1 pegfilgrastim 1 glofitamab 1 Topotecan 1 Rituximab 1 Prednisone 1 Positron Emission Tomography Computed Tomography 1 Paclitaxel 1 Methylprednisolone 1 Immunologic Techniques 1 Ifosfamide 1 Flow Cytometry 1 Etoposide 1 Dexamethasone 1 Clofarabine 1 Carboplatin 1 Bexarotene 1 Alemtuzumab 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Aggression × Etoposide × Clear all

NCT02471911 2022-04-12

KPT-330+RICE

Weill Medical College of Cornell University

Phase 1 Completed

Aggression, Lymphoma, Large B-Cell, Diffuse

Data powered by HemOnc (CC BY 4.0) Colophon ⚡